2005
Comparative genomic hybridization of ectopic pregnancies that fail methotrexate therapy
McKenzie L, El-Zimaity H, Krotz S, Laucirica R, Carson S, Buster J. Comparative genomic hybridization of ectopic pregnancies that fail methotrexate therapy. Fertility And Sterility 2005, 84: 1517-1519. PMID: 16275259, DOI: 10.1016/j.fertnstert.2005.04.064.Peer-Reviewed Original Research
2004
Characterizing ectopic pregnancies that rupture despite treatment with methotrexate
Dudley P, Heard M, Sangi-Haghpeykar H, Carson S, Buster J. Characterizing ectopic pregnancies that rupture despite treatment with methotrexate. Fertility And Sterility 2004, 82: 1374-1378. PMID: 15533363, DOI: 10.1016/j.fertnstert.2004.03.066.Peer-Reviewed Original ResearchConceptsTubal ruptureEctopic pregnancyRisk factorsHCG valuesHuman chorionic gonadotropin valuesRetrospective case-control analysisIndependent risk factorUrban medical centerCase-control analysisConcentrations of hCGEctopic gestationMTX administrationIndependent predictorsSurgical interventionGonadotropin valuesHCG concentrationsMAIN OUTCOMEMedical CenterMethotrexateImplantation sitesPregnancyTubal isthmusPatientsPredictive variablesTreatmentMajority of ectopic pregnancies that fail methotrexate are euploid by comparative genomic hybridization (CGH)
McKenzie L, El-Zimaity H, Krotz S, Amato P, Carson S, Buster J. Majority of ectopic pregnancies that fail methotrexate are euploid by comparative genomic hybridization (CGH). Fertility And Sterility 2004, 82: s285-s286. DOI: 10.1016/j.fertnstert.2004.07.767.Peer-Reviewed Original Research
1997
New technologies permit safe abortion at less than six weeks' gestation and provide timely detection of ectopic gestation
Edwards J, Carson S. New technologies permit safe abortion at less than six weeks' gestation and provide timely detection of ectopic gestation. American Journal Of Obstetrics And Gynecology 1997, 176: 1101-1106. PMID: 9166176, DOI: 10.1016/s0002-9378(97)70410-1.Peer-Reviewed Original ResearchConceptsWeeks' gestationEctopic pregnancyBeta-human chorionic gonadotropin measurementsElective abortionBeta-human chorionic gonadotropinPostoperative serum levelsEctopic gestationSerious complicationsSerum levelsTransvaginal ultrasonographyGestational sacVaginal ultrasonographyClose surveillanceGonadotropin measurementsUltrasonographic criteriaChorionic gonadotropinGestationPregnancyGreater riskComplete evacuationEarly abortionChorionic membraneSafe abortionAbortion procedureAbortion
1996
Single serum progesterone as a screen for ectopic pregnancy: exchanging specificity and sensitivity to obtain optimal test performance*
McCord M, Muram D, Buster J, Arheart K, Stovall T, Carson S. Single serum progesterone as a screen for ectopic pregnancy: exchanging specificity and sensitivity to obtain optimal test performance*. Fertility And Sterility 1996, 66: 513-516. PMID: 8816609, DOI: 10.1016/s0015-0282(16)58560-4.Peer-Reviewed Original ResearchConceptsViable intrauterine pregnancyEctopic pregnancyIntrauterine pregnancySpontaneous abortionDiagnostic accuracyCutoff valueFirst trimester pregnant womenSingle serum progesteroneInvasive diagnostic studiesTrimester pregnant womenHigh diagnostic accuracyPregnant womenSerum PSerum progesteroneUniversity HospitalRetrospective analysisMAIN OUTCOMEPregnancy
1995
Ectopic pregnancy
Buster J, Carson S. Ectopic pregnancy. Current Opinion In Obstetrics & Gynecology 1995, 7: 168-176. PMID: 7647267, DOI: 10.1097/00001703-199506000-00003.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsEctopic pregnancyLaparoscopic salpingostomyBeta-human chorionic gonadotropin measurementsSingle dose systemic methotrexateEarly first trimesterSurgical gold standardEffective nonsurgical treatmentSystemic methotrexateDose methotrexateSurgical complicationsNonsurgical treatmentFirst trimesterSimilar patientsDefinitive diagnosisGonadotropin measurementsSerum progesteroneEffective therapySurgical diseaseEarly diagnosisPregnancyDiagnostic algorithmGold standardMedical criteriaSalpingostomyPatients
1992
Serum progesterone and uterine curettage in differential diagnosis of ectopic pregnancy
Stovall T, Ling F, Carson S, Buster J. Serum progesterone and uterine curettage in differential diagnosis of ectopic pregnancy. Fertility And Sterility 1992, 57: 456-458. PMID: 1735503, DOI: 10.1016/s0015-0282(16)54866-3.Peer-Reviewed Original Research
1991
Methotrexate treatment of unruptured ectopic pregnancy: a report of 100 cases.
Stovall T, Ling F, Gray L, Carson S, Buster J. Methotrexate treatment of unruptured ectopic pregnancy: a report of 100 cases. Obstetrics And Gynecology 1991, 77: 749-53. PMID: 2014090.Peer-Reviewed Original ResearchConceptsUnruptured ectopic pregnancyEctopic pregnancyConservative surgical proceduresHCG titerPatient nosPrimary therapySurgical proceduresSide effectsPrevious ectopic pregnancyRecurrent ectopic pregnancyIdentifiable risk factorsOngoing clinical trialsCardiac activityTubal pregnancyPersistent diseaseFourth doseMedical therapyMethotrexate treatmentOutpatient protocolInvolved sideTubal patencyRisk factorsClinical trialsPregnancyPatientsLow human chorionic somatomammotropin fails to predict spontaneous resolution of unruptured ectopic pregnancies
Carson S, Stovall T, Ling F, Buster J. Low human chorionic somatomammotropin fails to predict spontaneous resolution of unruptured ectopic pregnancies. Fertility And Sterility 1991, 55: 629-630. PMID: 2001763, DOI: 10.1016/s0015-0282(16)54198-3.Peer-Reviewed Original Research
1989
Rising human chorionic somatomammotropin predicts ectopic pregnancy rupture following methotrexate chemotherapy
Carson S, Stovall T, Umstot E, Andersen R, Ling F, Buster J. Rising human chorionic somatomammotropin predicts ectopic pregnancy rupture following methotrexate chemotherapy. Fertility And Sterility 1989, 51: 593-597. PMID: 2466704, DOI: 10.1016/s0015-0282(16)60605-2.Peer-Reviewed Original ResearchConceptsHuman chorionic somatomammotropinEctopic pregnancyBeta-human chorionic gonadotropinEctopic pregnancy ruptureChorionic somatomammotropinSurgical therapyBeta-hCGMethotrexate chemotherapyMethotrexate treatmentMedical managementTrophoblastic activityHCS levelsChorionic gonadotropinAuthors' seriesPregnancyPatientsSensitive indicatorRuptureChemotherapyGonadotropinMethotrexateProgesteroneTherapyWomen